ACE2 a double-edged sword?
Angiotensin-converting enzyme 2 (ACE2) is the binding protein/receptor used by the new SARS-CoV-2, which causes 2019 coronavirus disease (COVID-19), to enter host cells [1,2]. In 2003, Li and colleagues [3] at the Harvard Medical School, USA had previously described that a protein (spike proteins -...
Guardado en:
| Autores principales: | Campagnole Santos, Maria Jose, Santos, Robson A. S., Magalhaes, Gisele S., Motta Santos, Daisy, Rodrigues Machado, Maria da Glória |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/148827 https://pmr.safisiol.org.ar/wp-content/uploads/2022/12/special_issue_coronavirus_2020.pdf |
| Aporte de: |
Ejemplares similares
-
Geração de uma colônia de camundongos transgênicos homozigotos K18-hACE2 para avaliação de vacina e candidatos terapêuticos contra SARS-CoV-2
por: BERENGENO, Andrea, et al.
Publicado: (2022) -
ACE-inhibitory peptides from bovine caseins released with peptidases from <i>Maclura pomifera</i> latex
por: Corrons, María Alicia, et al.
Publicado: (2017) -
Oxidative stress and cardiac contractility: a double edge sword?
por: Zavala, Maite Raquel, et al.
Publicado: (2021) -
The double-edged sword : how character makes and ruins presidents, from Washington to Clinton /
por: Shogan, Robert
Publicado: (1999) -
Influence of ACE inhibitors on the ECG
of acute renal hypertension induced rats
por: Moinuddin, Ghulam, et al.
Publicado: (2011)